Written by
Louise W Lu, PhD, MPH, BMLS
Written/Reviewed by
Alexandra V Goldberg, Registered Dietitian
Many people first notice changes in their joints not because of severe pain, but because one day something suddenly feels different:
- Your knees suddenly feel sore when walking upstairs
- Your body feels stiff after sitting for a long time
- Your knees start making “clicking” or “cracking” sounds during squats
- Your joints feel strangely achy before the weather changes
- You used to recover from exercise within two days, but now the discomfort lingers much longer
Many people instinctively think: “Am I just getting older?” Because for a long time, we’ve been taught to believe that joint pain is simply part of ageing. That joints gradually become “worn out” over time, and that osteoarthritis (OA) is mainly caused by long-term wear and tear.
But modern joint research is beginning to challenge that idea. Increasingly, international studies now suggest that osteoarthritis is not simply a problem of “age-related wear”. Instead, it is now understood as a whole-joint disease involving: cartilage, synovial tissue, bone, inflammation, metabolism, and even the immune system.
In other words, the real issue may not simply be whether the joints experience wear and tear — but whether the body can effectively regulate inflammation and repair these ongoing stresses and micro-damages.
“The real question is not whether the body experiences damage — but whether it can still keep up with repair.”
And perhaps this shift in understanding also explains something important: if osteoarthritis is not purely a problem of ageing and mechanical wear, then joint problems may not be limited to older adults.
For many people in their 30s and 40s, changes inside the joints may already have started quietly developing long before significant pain ever appears.
Why Is Modern Medicine Re-Thinking Osteoarthritis?
To understand why modern medicine is changing the way it views osteoarthritis, we first need to understand how a healthy joint is actually designed to function.
Many people think of a joint as simply “where two bones connect”. But in reality, a healthy joint is an extremely complex biological system. The surface of the bones is covered with cartilage, which helps absorb pressure and reduce friction; the synovium produces synovial fluid to lubricate and nourish the cartilage; and the surrounding muscles and ligaments help stabilise the joint and distribute mechanical force.
More importantly, these tissues are not static. A healthy joint is constantly undergoing a dynamic cycle of: damage, repair, and rebalancing. Even during normal daily activities such as walking, climbing stairs, or exercise, small amounts of stress and micro-damage occur continuously — but the body is usually able to repair these stresses efficiently.
Cartilage itself is not simply a passive “rubber cushion”. It is actually a highly active metabolic tissue. Under normal conditions, cartilage cells (chondrocytes) continuously renew type II collagen and proteoglycans in order to maintain cartilage elasticity, shock absorption, and low-friction movement.
The problem begins when the body is exposed long-term to chronic inflammation, obesity, oxidative stress, metabolic dysfunction, poor sleep, abnormal mechanical loading, or cellular ageing. Over time, the balance between damage and repair gradually begins to break down.
Modern research now suggests that in many cases, osteoarthritis is not simply caused by cartilage being “worn away”. Instead, cartilage cells gradually lose their normal repair capacity and begin entering a persistent “breakdown state”.
In this state, chondrocytes begin releasing large amounts of degradative enzymes, including MMPs (matrix metalloproteinases) and ADAMTS, which actively break down cartilage structure. At the same time, the cells continue releasing inflammatory mediators such as IL-1β and TNF-α, further accelerating cartilage destruction.
In other words, many cases of OA are not simply the result of cartilage being “worn out”, but rather the joint gradually entering a chronic state where:
Repair can no longer keep up with damage.
What many people also do not realise is that the pain of OA does not come only from cartilage itself. In fact, cartilage contains very few nerves. Much of the pain associated with osteoarthritis actually comes from synovitis, subchondral bone changes, and increased nerve sensitisation.
The synovium normally produces joint fluid to lubricate and nourish cartilage. However, when cartilage fragments, inflammatory mediators, and abnormal mechanical stress persist over time, the synovium gradually develops chronic low-grade inflammation.
Inflamed synovial tissue releases cytokines and prostaglandins, creating an increasingly “pro-inflammatory” joint environment. This not only accelerates cartilage degradation, but also amplifies pain signalling.
This helps explain why many people with OA experience not only pain during movement, but also morning stiffness, swelling, heat sensations, and aching discomfort when the weather changes.
At the same time, the bone underneath the cartilage — known as subchondral bone — also begins to change.
In the past, bone changes were thought to occur only after cartilage damage had already developed. But modern research suggests that abnormal bone metabolism may begin much earlier than previously believed.
Subchondral bone gradually develops microfractures, abnormal bone remodelling, and sclerosis, causing the bone tissue to become increasingly stiff and less capable of absorbing impact.
As a result, everyday mechanical forces are transmitted more directly into the cartilage, further accelerating joint damage.
At the same time, the body may begin forming osteophytes — commonly known as “bone spurs”. These are not ideal forms of repair, but rather maladaptive structural changes that reflect long-term abnormal loading and chronic inflammation.
From a modern medical perspective, osteoarthritis may be better understood as a type of:
“Chronic failed repair syndrome.”
Under normal conditions, joints experience small amounts of daily stress and micro-damage, but the body is usually able to repair them effectively. However, when chronic inflammation, metabolic dysfunction, oxidative stress, cellular ageing, and abnormal mechanical loading all persist together over time, the speed of repair gradually falls behind the speed of damage.
The joint then enters a prolonged state of chronic remodelling: simultaneous destruction and imperfect repair, eventually leading to cartilage degeneration, osteophyte formation, joint deformity, and chronic pain.
Why Is the Research Logic Behind Layla® Becoming Increasingly Aligned with Modern OA Medicine?
If the real problem behind osteoarthritis (OA) is not simply “wear and tear”, but rather chronic inflammation, impaired repair mechanisms, metabolic imbalance, ongoing cartilage breakdown, and deterioration of the entire joint environment, then modern joint management should not focus only on temporary pain suppression.
This is also why the research direction behind Layla® is not designed to target only a single structure, but instead focuses more broadly on:
- Regulation of chronic inflammation
- Stabilisation of the joint environment
- Long-term mobility support
- Tissue resilience and recovery capacity
- Overall joint function improvement
From the perspective of modern OA mechanisms, progressive joint deterioration is rarely driven by just one isolated factor.
When chronic inflammation persists, cartilage cells gradually shift from a “repair mode” into a “breakdown mode”; the synovium begins creating a pro-inflammatory environment; subchondral bone gradually stiffens; pain signalling becomes amplified; and the body becomes increasingly unable to repair accumulated micro-damage over time.
The research philosophy behind Layla® (PG201) is intended to provide broader and longer-term support for many of these core mechanisms involved in modern OA.
Instead, it focuses more on: inflammation balance, joint mobility, long-term tolerance, and overall joint function management.
According to currently available research data, PG201 has undergone:
- Randomised
- Double-blind
- Double-dummy
- Multicentre
- Phase IV clinical research
The study included: 124 patients with knee osteoarthritis, primarily individuals with Kellgren–Lawrence grade 2–3 OA.
The study lasted 12 weeks and compared PG201 with an active control group. Outcome measures included:
- Pain changes (VAS)
- WOMAC score
- Joint function
- Mobility
- Quality of life (EQ-5D)
- Long-term safety and tolerability
The results showed that PG201 demonstrated meaningful improvements in pain, WOMAC score, joint function, and quality of life measures.
More importantly, the study specifically highlighted that:
With long-term use, Layla® (PG201) demonstrated good tolerability and safety.
This is particularly important because osteoarthritis itself is a long-term chronic condition.
The real challenge is often not simply “short-term pain relief,” but rather:
Whether the body can maintain lower inflammation, a more stable joint environment, and sustainable mobility over time.
This is also why modern international OA management increasingly emphasises:
- Long-term management
- Functional maintenance
- Reduction of chronic inflammation
- Preservation of mobility
- Improvement of the overall recovery environment
Osteoarthritis is no longer viewed simply as: “treating wherever it hurts.”
Modern joint care is increasingly about helping the entire joint system return to a state that is: more stable, less inflammatory, and better able to recover.
